Cargando…

Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI

When glioblastoma multiforme (GBM) is treated with anti-vascular endothelial growth factor (VEGF) agents, it commonly exhibits tumor progression due to the development of resistance, which results in a dismal survival rate. GBM tumors contain a large number of monocytes/macrophages, which have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hye Rim, Kumari, Nisha, Thi Vu, Hien, Kim, Hyeonjin, Park, Chul-Kee, Choi, Seung Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668454/ https://www.ncbi.nlm.nih.gov/pubmed/31366997 http://dx.doi.org/10.1038/s41598-019-47438-4

Ejemplares similares

Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging
por: Cho, Hye Rim, et al.
Publicado: (2019)

Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging
por: Cho, Hye Rim, et al.
Publicado: (2016)

New perspectives in glioblastoma antiangiogenic therapy
por: Popescu, Alisa Madalina, et al.
Publicado: (2015)

Cerebral Blood Volume Calculated by Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Preliminary Correlation Study with Glioblastoma Genetic Profiles
por: Ryoo, Inseon, et al.
Publicado: (2013)

Cerebral Blood Volume Analysis in Glioblastomas Using Dynamic Susceptibility Contrast-Enhanced Perfusion MRI: A Comparison of Manual and Semiautomatic Segmentation Methods
por: Jung, Seung Chai, et al.
Publicado: (2013)

Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients()()
por: Jafari-Khouzani, Kourosh, et al.
Publicado: (2015)

Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting
por: Gu, Zeming, et al.
Publicado: (2022)

Assessment of Early Therapeutic Response to Nitroxoline in Temozolomide-Resistant Glioblastoma by Amide Proton Transfer Imaging: A Preliminary Comparative Study with Diffusion-weighted Imaging
por: Kumari, Nisha, et al.
Publicado: (2019)

Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
por: Woodall, Ryan T, et al.
Publicado: (2021)

Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy
por: Skolnik, Aaron D., et al.
Publicado: (2018)

Contemporary Updates on Clinical Trials of Antiangiogenic Agents in the Treatment of Glioblastoma Multiforme
por: Kochar, Arshneel Singh, et al.
Publicado: (2018)

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
por: Ebos, John ML, et al.
Publicado: (2014)

Dynamic Contrast-Enhanced MRI for Monitoring Antiangiogenic Treatment: Determination of Accurate and Reliable Perfusion Parameters in a Longitudinal Study of a Mouse Xenograft Model
por: Song, Youngkyu, et al.
Publicado: (2013)

Creation of a Rodent Model of Abdominal Aortic Aneurysm by Blocking Adventitial Vasa Vasorum Perfusion
por: Tanaka, Hiroki, et al.
Publicado: (2017)

Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature
por: Khattab, Mohamed H., et al.
Publicado: (2015)

In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma
por: Senrung, Anna, et al.
Publicado: (2023)

Leakage correction improves prognosis prediction of dynamic susceptibility contrast perfusion MRI in primary central nervous system lymphoma
por: Kim, Yeon Soo, et al.
Publicado: (2018)

Whole Animal Perfusion Fixation for Rodents
por: Gage, Gregory J., et al.
Publicado: (2012)

Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
por: Chinot, Olivier L., et al.
Publicado: (2013)

Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
por: de Groot, John, et al.
Publicado: (2012)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019)

Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy
por: Stadlbauer, Andreas, et al.
Publicado: (2017)

Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations
por: Nery de Albuquerque Rego, Gabriel, et al.
Publicado: (2020)

Constitutive and Stress-induced Expression of CCL5 Machinery in Rodent Retina
por: Duncan, D'Anne S., et al.
Publicado: (2017)

Multiparametric magnetic resonance imaging features of a canine glioblastoma model
por: Lee, Seunghyun, et al.
Publicado: (2021)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI
por: Pak, Elena, et al.
Publicado: (2021)

Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis
por: Cho, Hye Rim, et al.
Publicado: (2018)

Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease
por: Yadav, Nishtha, et al.
Publicado: (2023)

Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI
por: Shim, Ka Young, et al.
Publicado: (2021)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2015)

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018)

Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane
por: Dallemole, Danieli Rosane, et al.
Publicado: (2021)

Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
por: Lee, Eun Kyoung, et al.
Publicado: (2015)

Expression and prognostic significance of CCL11/CCR3 in glioblastoma
por: Tian, Min, et al.
Publicado: (2016)

Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options
por: Heo, Young Jin, et al.
Publicado: (2015)

Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients
por: Kim, Tae-Hyung, et al.
Publicado: (2016)

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography
por: Zhu, Xiao-Dong, et al.
Publicado: (2011)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ck2rqfitemqrt3mmh0fhivbh9e